Tumour mutational burden (TMB) assessment using next generation sequencing (NGS) for the prediction of complete response (CR) to immunotherapy (IO) in metastatic melanoma

T. G. Humphries; T. Giardina; N. Mesbah Ardakani; M. A. Khattak; Tarek Meniawy; A. Jacques; E. S. Gray; B. Amanuel; M. Millward

doi:10.1016/j.annonc.2021.08.1438

Tumour mutational burden (TMB) assessment using next generation sequencing (NGS) for the prediction of complete response (CR) to immunotherapy (IO) in metastatic melanoma

T. G. Humphries, T. Giardina, N. Mesbah Ardakani, M. A. Khattak, Tarek Meniawy, A. Jacques, E. S. Gray, B. Amanuel, M. Millward

Internal Medicine

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Article number	1053P
Pages (from-to)	S879-S879
Number of pages	1
Journal	Annals of Oncology
Volume	32
DOIs	https://doi.org/10.1016/j.annonc.2021.08.1438
Publication status	Published - 2021
Event	Congress of the European-Society-for-Medical-Oncology (ESMO) - Duration: 16 Sept 2021 → 21 Sept 2021

Access to Document

10.1016/j.annonc.2021.08.1438

Cite this

Humphries, T. G., Giardina, T., Ardakani, N. M., Khattak, M. A., Meniawy, T., Jacques, A., Gray, E. S., Amanuel, B., & Millward, M. (2021). Tumour mutational burden (TMB) assessment using next generation sequencing (NGS) for the prediction of complete response (CR) to immunotherapy (IO) in metastatic melanoma. Annals of Oncology, 32, S879-S879. [1053P]. https://doi.org/10.1016/j.annonc.2021.08.1438

@article{882898569589401dbb48171f6597826b,

title = "Tumour mutational burden (TMB) assessment using next generation sequencing (NGS) for the prediction of complete response (CR) to immunotherapy (IO) in metastatic melanoma",

author = "Humphries, {T. G.} and T. Giardina and Ardakani, {N. Mesbah} and Khattak, {M. A.} and Tarek Meniawy and A. Jacques and Gray, {E. S.} and B. Amanuel and M. Millward",

year = "2021",

doi = "10.1016/j.annonc.2021.08.1438",

language = "English",

volume = "32",

pages = "S879--S879",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

note = "Congress of the European-Society-for-Medical-Oncology (ESMO) ; Conference date: 16-09-2021 Through 21-09-2021",

}

Humphries, TG, Giardina, T, Ardakani, NM, Khattak, MA, Meniawy, T, Jacques, A, Gray, ES, Amanuel, B & Millward, M 2021, 'Tumour mutational burden (TMB) assessment using next generation sequencing (NGS) for the prediction of complete response (CR) to immunotherapy (IO) in metastatic melanoma', Annals of Oncology, vol. 32, 1053P, pp. S879-S879. https://doi.org/10.1016/j.annonc.2021.08.1438

Tumour mutational burden (TMB) assessment using next generation sequencing (NGS) for the prediction of complete response (CR) to immunotherapy (IO) in metastatic melanoma. / Humphries, T. G.; Giardina, T.; Ardakani, N. Mesbah et al.
In: Annals of Oncology, Vol. 32, 1053P, 2021, p. S879-S879.

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

TY - JOUR

T1 - Tumour mutational burden (TMB) assessment using next generation sequencing (NGS) for the prediction of complete response (CR) to immunotherapy (IO) in metastatic melanoma

AU - Humphries, T. G.

AU - Giardina, T.

AU - Ardakani, N. Mesbah

AU - Khattak, M. A.

AU - Meniawy, Tarek

AU - Jacques, A.

AU - Gray, E. S.

AU - Amanuel, B.

AU - Millward, M.

PY - 2021

Y1 - 2021

U2 - 10.1016/j.annonc.2021.08.1438

DO - 10.1016/j.annonc.2021.08.1438

M3 - Abstract/Meeting Abstract

SN - 0923-7534

VL - 32

SP - S879-S879

JO - Annals of Oncology

JF - Annals of Oncology

M1 - 1053P

T2 - Congress of the European-Society-for-Medical-Oncology (ESMO)

Y2 - 16 September 2021 through 21 September 2021

ER -